Payment overview · 2025
General Payments
$324.86
10 reported records · 8 companies
Healthcare provider profile · identity verified
Michael Louis Antolini
Allopathic & Osteopathic Physicians|Family Medicine · FAYETTEVILLE, WV · NPI 1851659387
Verified facts
What the public records show
CMS Open Payments records show Michael Louis Antolini received $324.86 in general payments during 2025 across 10 reported records.
GlaxoSmithKline, LLC. accounted for 30.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 12 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Arexvy, Eliquis, Ozempic.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 137 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Trelegy Ellipta by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 117 claims for Ozempic by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1156 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XELJANZ as an associated drug or biological on 32588 records involving 8614 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Xeljanz by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $97.69 | 30.1% | 2 | 2025 |
| Kowa Pharmaceuticals America, Inc. | Unresolved — no canonical attribution shown | $89.60 | 27.6% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $35.02 | 10.8% | 2 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $25.55 | 7.9% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $23.40 | 7.2% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $20.36 | 6.3% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $17.53 | 5.4% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.71 | 4.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $324.86 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $97.69 | 2 | 2025 |
Source payment records
|
|||||
| ZORYVE Normalized: zoryve |
Drug | Kowa Pharmaceuticals America, Inc. | $89.60 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $35.02 | 2 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $25.55 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $25.55 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 2 Normalized: freestyle libre 2 |
Device | Abbott Laboratories | $23.40 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $20.36 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $20.36 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $17.53 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.71 | 1 | 2025 |
Source payment records
|
|||||
| BEXSERO Normalized: bexsero |
Biological | GlaxoSmithKline, LLC. | $13.60 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $13.60 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AREXVY arexvy |
2025 | Arexvy | 2024 | 137 | exact normalized | Medicare Part D |
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 1156 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 117 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
137 | 134 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
46 | 15 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
117 | 21 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1156 | 112 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | XELJANZ open payments reported associated product |
CMS Open Payments — General Payments 32588 supporting records · 8614 recipient NPIs · example record 1228794176 |
Xeljanz · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1547 | 266 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1363 | 186 |
| Eliquis | Apixaban | 1156 | 112 |
| Furosemide | Furosemide | 1156 | 168 |
| Pantoprazole Sodium | Pantoprazole Sodium | 994 | 170 |
| Gabapentin | Gabapentin | 983 | 92 |
| Metoprolol Succinate | Metoprolol Succinate | 845 | 163 |
| Potassium Chloride | Potassium Chloride | 756 | 124 |
| Amlodipine Besylate | Amlodipine Besylate | 736 | 155 |
| Metoprolol Tartrate | Metoprolol Tartrate | 694 | 124 |
| Omeprazole | Omeprazole | 675 | 124 |
| Tamsulosin Hcl | Tamsulosin Hcl | 606 | 102 |
| Lisinopril | Lisinopril | 597 | 159 |
| Sertraline Hcl | Sertraline Hcl | 565 | 65 |
| Losartan Potassium | Losartan Potassium | 534 | 96 |
| Montelukast Sodium | Montelukast Sodium | 508 | 105 |
| Trazodone Hcl | Trazodone Hcl | 497 | 77 |
| Lorazepam | Lorazepam | 472 | 32 |
| Metformin Hcl | Metformin Hcl | 471 | 88 |
| Clopidogrel | Clopidogrel Bisulfate | 459 | 87 |
| Donepezil Hcl | Donepezil Hcl | 454 | 61 |
| Buspirone Hcl | Buspirone Hcl | 445 | 75 |
| Famotidine | Famotidine | 414 | 61 |
| Levetiracetam | Levetiracetam | 403 | 40 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 369 | 34 |
| Simvastatin | Simvastatin | 369 | 62 |
| Duloxetine Hcl | Duloxetine Hcl | 355 | 62 |
| Divalproex Sodium | Divalproex Sodium | 352 | 42 |
| Mirtazapine | Mirtazapine | 284 | 40 |
| Memantine Hcl | Memantine Hcl | 271 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 265 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 261 | 48 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 243 | 40 |
| Finasteride | Finasteride | 237 | 31 |
| Hydralazine Hcl | Hydralazine Hcl | 225 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 220 | 57 |
| Escitalopram Oxalate | Escitalopram Oxalate | 219 | 47 |
| Ropinirole Hcl | Ropinirole Hcl | 219 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 218 | 64 |
| Fluticasone Propionate | Fluticasone Propionate | 214 | 77 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 196 | 13 |
| Spironolactone | Spironolactone | 183 | 40 |
| Jardiance | Empagliflozin | 179 | 19 |
| Clonidine Hcl | Clonidine Hcl | 177 | 20 |
| Xarelto | Rivaroxaban | 177 | 31 |
| Sucralfate | Sucralfate | 176 | 23 |
| Warfarin Sodium | Warfarin Sodium | 173 | suppressed |
| Carvedilol | Carvedilol | 169 | 32 |
| Baclofen | Baclofen | 166 | 21 |
| Allopurinol | Allopurinol | 165 | 30 |
| Citalopram Hbr | Citalopram Hydrobromide | 165 | 27 |
| Dicyclomine Hcl | Dicyclomine Hcl | 165 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 165 | 31 |
| Amiodarone Hcl | Amiodarone Hcl | 163 | 29 |
| Entresto | Sacubitril/Valsartan | 156 | 27 |
| Glipizide | Glipizide | 151 | 33 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 145 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 145 | 40 |
| Meloxicam | Meloxicam | 143 | 32 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 142 | 34 |
| Tramadol Hcl | Tramadol Hcl | 141 | 23 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 137 | 134 |
| Linzess | Linaclotide | 136 | 26 |
| Ranolazine Er | Ranolazine | 134 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 131 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 131 | 20 |
| Clonazepam | Clonazepam | 129 | 13 |
| Atenolol | Atenolol | 126 | 23 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 126 | 19 |
| Benztropine Mesylate | Benztropine Mesylate | 125 | suppressed |
| Prednisone | Prednisone | 124 | 29 |
| Alendronate Sodium | Alendronate Sodium | 123 | 23 |
| Digoxin | Digoxin | 123 | 16 |
| Pregabalin | Pregabalin | 121 | 12 |
| Mounjaro | Tirzepatide | 120 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 118 | 12 |
| Metformin Hcl Er | Metformin Hcl | 118 | 17 |
| Ozempic | Semaglutide | 117 | 21 |
| Ezetimibe | Ezetimibe | 116 | 23 |
| Farxiga | Dapagliflozin Propanediol | 116 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 115 | 24 |
| Latanoprost | Latanoprost | 114 | 17 |
| Torsemide | Torsemide | 113 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 105 | 15 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 102 | 22 |
| Ibuprofen | Ibuprofen | 101 | 34 |
| Januvia | Sitagliptin Phosphate | 101 | 12 |
| Midodrine Hcl | Midodrine Hcl | 100 | 19 |
| Diazepam | Diazepam | 99 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 97 | 17 |
| Tradjenta | Linagliptin | 91 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 90 | 16 |
| Doxazosin Mesylate | Doxazosin Mesylate | 86 | 15 |
| Bupropion Xl | Bupropion Hcl | 83 | 15 |
| Alprazolam | Alprazolam | 82 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 82 | 14 |
| Haloperidol | Haloperidol | 81 | suppressed |
| Primidone | Primidone | 81 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 79 | 38 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 79 | 12 |
| Brilinta | Ticagrelor | 75 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 73 | 18 |
| Phenobarbital | Phenobarbital | 73 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 69 | 15 |
| Fenofibrate | Fenofibrate | 68 | 12 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 68 | 30 |
| Trulicity | Dulaglutide | 68 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 67 | suppressed |
| Topiramate | Topiramate | 66 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 64 | 19 |
| Cilostazol | Cilostazol | 63 | suppressed |
| Lamotrigine | Lamotrigine | 63 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | 18 |
| Nifedipine Er | Nifedipine | 62 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 62 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 61 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 60 | 23 |
| Rivastigmine | Rivastigmine Tartrate | 59 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 58 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 58 | 16 |
| Ketoconazole | Ketoconazole | 57 | 18 |
| Sotalol | Sotalol Hcl | 57 | suppressed |
| Austedo | Deutetrabenazine | 56 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 56 | suppressed |
| Lactulose | Lactulose | 56 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 55 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 55 | 15 |
| Propranolol Hcl Er | Propranolol Hcl | 55 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 55 | 14 |
| Lurasidone Hcl | Lurasidone Hcl | 54 | suppressed |
| Synthroid | Levothyroxine Sodium | 54 | 15 |
| Acyclovir | Acyclovir | 53 | suppressed |
| Celecoxib | Celecoxib | 53 | 11 |
| Risperidone | Risperidone | 53 | suppressed |
| Acetazolamide | Acetazolamide | 52 | suppressed |
| Cephalexin | Cephalexin | 52 | 35 |
| Memantine Hcl Er | Memantine Hcl | 52 | suppressed |
| Methylprednisolone | Methylprednisolone | 51 | 40 |
| Olanzapine | Olanzapine | 51 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 50 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 50 | 12 |
| Nystatin | Nystatin | 49 | 28 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 49 | 36 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 48 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 47 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 46 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 46 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 46 | 15 |
| Bydureon Bcise | Exenatide Microspheres | 45 | suppressed |
| Cefdinir | Cefdinir | 45 | 34 |
| Fenofibrate | Fenofibrate,micronized | 43 | suppressed |
| Fluconazole | Fluconazole | 43 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 43 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 41 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 41 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 40 | suppressed |
| Trimethoprim | Trimethoprim | 40 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 31 |
| Bupropion Hcl Sr | Bupropion Hcl | 39 | suppressed |
| Naproxen | Naproxen | 39 | suppressed |
| Xifaxan | Rifaximin | 39 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 25 |
| Myrbetriq | Mirabegron | 38 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 36 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 36 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | 16 |
| Zenpep | Lipase/Protease/Amylase | 36 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 35 | suppressed |
| Azithromycin | Azithromycin | 34 | 30 |
| Colchicine | Colchicine | 34 | 12 |
| Glipizide Er | Glipizide | 34 | suppressed |
| Glyburide | Glyburide | 34 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 34 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 34 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Cimetidine | Cimetidine | 32 | suppressed |
| Creon | Lipase/Protease/Amylase | 32 | suppressed |
| Metronidazole | Metronidazole | 32 | suppressed |
| Mupirocin | Mupirocin | 32 | 13 |
| Lovastatin | Lovastatin | 31 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 30 | suppressed |
| Lansoprazole | Lansoprazole | 30 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Ondansetron Odt | Ondansetron | 30 | 16 |
| Modafinil | Modafinil | 29 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 28 | suppressed |
| Klor-Con 10 | Potassium Chloride | 28 | suppressed |
| Levofloxacin | Levofloxacin | 28 | 21 |
| Enulose | Lactulose | 27 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 27 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 27 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Lidocaine | Lidocaine | 26 | suppressed |
| Nitroglycerin | Nitroglycerin | 26 | 17 |
| Budesonide | Budesonide | 25 | 14 |
| Lacosamide | Lacosamide | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Hydroxyurea | Hydroxyurea | 24 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 23 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | suppressed |
| Pentoxifylline | Pentoxifylline | 23 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 23 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 22 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 22 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Vascepa | Icosapent Ethyl | 22 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 21 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | 11 |
| Calcipotriene | Calcipotriene | 20 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 20 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 20 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 14 |
| Glimepiride | Glimepiride | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Levetiracetam Er | Levetiracetam | 19 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 19 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 19 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Meropenem-0.9% Nacl | Meropenem-0.9% Sodium Chloride | 18 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 17 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 17 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 17 | suppressed |
| Metolazone | Metolazone | 17 | suppressed |
| Scopolamine | Scopolamine | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Acarbose | Acarbose | 16 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 16 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 16 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Ibu | Ibuprofen | 15 | suppressed |
| Klor-Con M20 | Potassium Chloride | 15 | suppressed |
| Lubiprostone | Lubiprostone | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 15 | suppressed |
| Roflumilast | Roflumilast | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Acetazolamide Er | Acetazolamide | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 14 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 14 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 14 | suppressed |
| Nystop | Nystatin | 14 | 12 |
| Ramipril | Ramipril | 14 | suppressed |
| Xeljanz | Tofacitinib Citrate | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Desloratadine | Desloratadine | 13 | suppressed |
| Fingolimod | Fingolimod Hcl | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 13 | suppressed |
| Abiraterone Acetate | Abiraterone Acetate | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 12 | suppressed |
| Testosterone | Testosterone | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $324.86 · 10 records | GlaxoSmithKline, LLC. | AREXVY, BEXSERO, Cologuard Collection Kit, Dexcom G6 Transmitter, ELIQUIS, FREESTYLE LIBRE 2, Kerendia, NURTEC ODT, Ozempic, Rybelsus, SHINGRIX, ZORYVE | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Arexvy play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error